| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/12/2007 | WO2006091716A3 Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| 07/12/2007 | US20070161787 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 07/12/2007 | US20070161689 Indoles having anti-diabetic activity |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161664 Therapeutic compounds |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161645 Thiazole inhibitors targeting resistant kinase mutations |
| 07/12/2007 | US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin |
| 07/12/2007 | US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders |
| 07/12/2007 | US20070161633 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 07/12/2007 | US20070161631 Substituted Phenoxyacetic Acids |
| 07/12/2007 | US20070161626 Substituted Indazoles, Compositions Containing The Same, And The Preparation And Use Thereof |
| 07/12/2007 | US20070161625 phenothiazinium compounds; for healing process and cosmetic uses; for problems associated with vascular disease, malnutrition, stress, cancer radio- or chemotherapy, compromise of immune system or due to normal aging process; as a cream, suspension, emulsion, gel, ointment, salve, stick, soap, paste |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | US20070160931 methine dye containing C4O2.C6.C4O2 ring; thermal stability, light fastness; reproduction/playback of the high density information recordings |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2636264A1 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2635580A1 Substituted bis-amide metalloprotease inhibitors |
| 07/12/2007 | CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | CA2634195A1 Piperazine compounds with a herbicidal action |
| 07/12/2007 | CA2632854A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 07/12/2007 | CA2632694A1 Isoxazolines for controlling invertebrate pests |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1806605A1 Filter and cyanine compound |
| 07/11/2007 | EP1806346A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 07/11/2007 | EP1805172A1 4-methoxymethyl-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors |
| 07/11/2007 | EP1805171A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 07/11/2007 | EP1805169A1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses |
| 07/11/2007 | EP1805165A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 07/11/2007 | EP1805155A1 Thrombopoietin activity modulating compounds and methods |
| 07/11/2007 | EP1805154A2 Pharmaceutical compositions |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/11/2007 | EP1804797A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 07/11/2007 | EP1622899B1 Pioglitazone sulfate, pharmaceutical compositions and their use |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1355886B1 Fused heterocyclic compounds |
| 07/11/2007 | EP1309597B1 Polymorphs of an epothilone analog |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1135128B1 Novel method of treatment |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997643A Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 07/11/2007 | CN1997640A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 07/11/2007 | CN1995038A Preparation method of ziprasidone |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325475C Quinoline derivatives and their use as mycobacterial inhibitors |
| 07/11/2007 | CN1325472C Phenyl-substituted cyclic enaminones |
| 07/11/2007 | CN1325052C Benzothiazole derivatives |
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 07/10/2007 | US7241899 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 07/10/2007 | US7241895 The polymorphic forms of the present invention are more active as antidiabetic agent |
| 07/10/2007 | US7241887 3-azabicyclo[3.2.1]octane derivatives |
| 07/10/2007 | US7241803 Compounds for inhibition of HIV infection by blocking HIV entry |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241786 Compounds inhibit A beta -peptide production; may be used for treatment of Alzheimer's disease and other neurological disorders in mammals, including humans |
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/10/2007 | US7241761 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 07/10/2007 | US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics |
| 07/10/2007 | US7241759 Cholecystokinin receptors as modulators to mediate diseases and gastrointestinal disorders |
| 07/10/2007 | US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/05/2007 | WO2007076460A2 Substituted thiazole ureas useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | WO2007075896A2 Heterocyclic cytokine inhibitors |
| 07/05/2007 | WO2007075852A2 Calcium channel antagonists |
| 07/05/2007 | WO2007075847A2 Glucokinase activators |
| 07/05/2007 | WO2007075749A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/05/2007 | WO2007075297A2 Muscarinic agonists and methods of use thereof |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007056366A3 Compounds and compositions as ppar modulators |
| 07/05/2007 | WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 07/05/2007 | WO2007047474A3 Biphenyl derivatives as modulators of voltage gated ion channels |
| 07/05/2007 | WO2007016228A3 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 07/05/2007 | WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 07/05/2007 | US20070155966 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 07/05/2007 | US20070155959 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155807 Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents |
| 07/05/2007 | US20070155806 Novel luciferin derivatives |
| 07/05/2007 | US20070155805 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease |
| 07/05/2007 | US20070155804 Mitotic kinesin inhibitor |
| 07/05/2007 | US20070155798 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155792 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155763 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the phophylaxis and treatment of disorders related thereto |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155733 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidone hydrochloride; useful in reversing multidrug resistance |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |